Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02150967
Title A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

cholangiocarcinoma

Therapies

Infigratinib

Age Groups: adult
Covered Countries USA | ITA | ESP | DEU | BEL

Facility Status City State Zip Country Details
QED Investigative Site Phoenix Arizona 85054 United States Details
QED Investigative Site Los Angeles California 90033 United States Details
QED Investigative Site Los Angeles California 90095 United States Details
QED Investigative Site San Francisco California 94158 United States Details
QED Investigative Site Boston Massachusetts 02114 United States Details
QED Investigative Site Detroit Michigan 48201 United States Details
QED Investigative Site New York New York 10016 United States Details
QED Investigative Site New York New York 10029 United States Details
QED Investigative Site New York New York 10065 United States Details
QED Investigative Site Columbus Ohio 43221 United States Details
QED Investigative Site Houston Texas 77030-4009 United States Details
QED Investigative Site Brussels 1200 Belgium Details
QED Investigative Site Leuven 3000 Belgium Details
QED Investigative Site Koeln Nordrhein-Westfalen 50937 Germany Details
QED Investigative Site Heidelberg 69120 Germany Details
QED Investigative Site Tuebingen Germany Details
QED Investigative Site Ancona AN 60126 Italy Details
QED Investigative Site Milano MI 20132 Italy Details
QED Investigative Site Roma RM 00168 Italy Details
QED Investigative Site Seoul Korea 03080 Korea, Republic of Details
QED Investigative Site Seoul Korea 06351 Korea, Republic of Details
QED Investigative Site Moscow 125367 Russian Federation Details
QED Investigative Site Volzhskiy 404133 Russian Federation Details
QED Investigative Site Singapore 119228 Singapore Details
QED Investigative Site Singapore 169610 Singapore Details
QED Investigative Site Barcelona 8035 Spain Details
QED Investigative Site Barcelona 8908 Spain Details
QED Investigative Site Madrid 28050 Spain Details
QED Investigative Site Taipei Taiwan ROC 10041 Taiwan Details
QED Investigative Site Zhunan 35053 Taiwan Details
QED Investigative Site Khon Kaen THA 40002 Thailand Details
QED Investigative Site Bangkok 10330 Thailand Details
QED Investigative Site Bangkok 10400 Thailand Details
QED Investigative Site Bebington CH63 4JY United Kingdom Details
QED Investigative Site Birmingham B15 2TH United Kingdom Details
QED Investigative Site Manchester M20 4BX United Kingdom Details
QED Investigative Site Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field